Duloxetine (ajanta, Orspec)
Duloxetine capsules (30 mg) made by Ajanta and sold under the brand name Orspec are being recalled in New Zealand. The recall affects supplies distributed to hospitals, pharmacies, and laboratories. The specific reason for the recall is not detailed in the information provided.
- Recalling firm
- Grafton Pharmacy Ltd
- Product
- Duloxetine (Ajanta, Orspec). [Medicine]. Form: Capsule 30 mg DR
- Reason
- Sponsor proposing pharmacy level recall due to oos results for N-Nitroso Duloxetine impurity.
- Classification
- Class I
- Category
- drug recall
- Country
- New Zealand
- Agency
- MEDSAFE
- Recall date
- 2026-06-03
- Status
- Ongoing
- Distribution
- New Zealand - Hospital/Pharmacy/Laboratory
Official recall notice from MEDSAFE
Recall details on Nibble Recalls: https://trynibble.app/recalls/1837953b-ea38-404e-b594-b76dd0bb5208